Kongressthemen NAFLD is the leading cause of chronic liver disease not only in Western countries but also among developing countries of the Far East, South Asia, the Middle East, and Latin America. In the US and Europe, nearly 40% of the population have NAFLD and approximately 20% of these individuals are likely to develop progressive liver disease (i.e. NASH) that lead to liver fibrosis and cirrhosis. Another emerging challenge is hepatocellular cancer which increasingly arises in precirrhotic stages.
Kongressorganizer (PCO) European Association for the Study of the Liver (EASL)
Anmerkungen Speakers: Prof. Ali Canbay (Germany), Prof. Claus Hellebrand (Germany), Prof. Wing-Kin Syn (United States), Prof. Michael Trauner (Austria)
Kongressgebühr EASL Member (VAT exckusive): EUR 450 ,
Non Member (VAT exckusive): EUR 550 ,
Young Investigator and Nurse (EASL Member - VAT exckusive): EUR 150 ,
Young Investigator and Nurse (Non Member - VAT exckusive): EUR 200
Veranstalter Kontakt 83 Great Titchfield Street W1W 6RH London Großbritannien
